Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCohort Regulatory News (CHRT)

Share Price Information for Cohort (CHRT)

Share Price is delayed by 15 minutes
Get Live Data
1,256.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 12.00 (0.963%)
Market Cap: £575.57m
CHRT Live PriceLast checked at - London Stock Exchange

Intraday Cohort Share Chart

Acquisition

1 Oct 2014 07:00

RNS Number : 0900T
Cohort PLC
01 October 2014
 



01 October 2014

 

Cohort plc

("Cohort" or "the Group")

 

Cohort plc acquires J+S Ltd

 

 

Cohort, the independent technology group, is pleased to announce the acquisition of J+S Limited ('J+S' or 'the Company'), an independent systems and in-service support provider for the defence and offshore energy markets, from its shareholders for a cash consideration of £12 million.

Highlights:

 

· Total cash consideration of £12m, payable from Cohort's existing resources

· J+S provides the Group with new capabilities in defence, offered to the UK Royal Navy and other customers globally, and offshore energy

· J+S will be integrated into Cohort's existing subsidiary SEA

· Potential to offer enhanced technology solutions, support J+S's growth opportunities and to extend SEA's access to export markets

· Acquisition expected to be immediately earnings enhancing

 

Overview of J+S Ltd:

J+S is a leading UK supplier of systems and in-service support for the defence and offshore energy markets. Its principal operating site is in Barnstaple and it also has a facility in Aberdeen. Its defence products include sonar systems, torpedo launchers and a range of other naval equipment. J+S has made sales in Canada, Malaysia and the wider Asia Pacific region, with a total of 12 per cent of 2012/13 revenue coming from outside the UK. The Company expects this proportion to increase in 2013/14. Established in 1956, J+S currently employs 137 staff across its two sites.

In the year ended 30 September 2013, J+S booked orders of £34.9m (2012: £8.8m). This was a record for the Company with a particularly strong performance from its defence business. The year-end order book stood at £36.5m (2012: £15.0m). It reported an operating profit of £1.5m (2012: £1.4m) on revenue up 4.4% to £13.2m (2012: £12.6m) for the year.

J+S expects to deliver turnover of £14m for the year to 30 September 2014 with an operating profit of £1.5m and Cohort believes growth prospects for subsequent years are strong. The Company's order book at the end of September 2014 is expected to be in excess of £33m.

At 30 September 2013, the gross assets of J+S were £8.7m and the net assets £3.7m. J+S's executive management will remain in place following the transaction, integrated into SEA's management team under Managing Director Stephen Hill.

Background to and reasons for the acquisition:

The acquisition of J+S is in line with the Group's stated strategy to accelerate its growth by making targeted acquisitions, complementing organic growth, whether as stand-alone members of the Group or as "bolt-in" acquisitions to our existing subsidiaries. The Board believes that this strategy of investing the Group's significant cash resources (which stood at over £14m as at 31 August 2014) partly in acquisitions will provide enhanced returns to shareholders.

J+S meets our stated criteria for bolt-in acquisitions where we look for businesses with capabilities and/or customer relationships that are closely linked to one of our existing subsidiaries. J+S's defence capabilities and products, notably its sonar array products, well-established manufacturing capability and long-term customer support relationships, are highly complementary to SEA's. We would expect to integrate J+S fully within SEA, leading to both cost savings and benefits from shared access to markets and technologies.

J+S's established production capability will be able to meet SEA's growing needs for submarine communication and other system manufacture. SEA's expertise in certain technology areas offers the potential for enhanced product offerings. The acquisition of J+S will extend SEA's reach internationally, by building on the strong foothold J+S has in Canada, Malaysia and the wider Asia Pacific region. It also brings a growing capability in adjacent markets including offshore energy.

Terms of the acquisition:

J+S was acquired from its shareholders, comprising David Jeffries, Chairman, and a number of other former and current employees, on a cash free / debt free basis for a consideration of £12m. This will be paid using Cohort's existing financial resources which included over £14m of net cash as at 31 August 2014 (after payment of the £6.0m initial consideration for the MCL transaction). Cohort retains unutilised banking facilities comprising an overdraft facility of £7.5m.

Andrew Thomis, Chief Executive Officer of Cohort, said:

"The acquisition of J+S represents Cohort's second significant step forward in recent months, following the acquisition of MCL in July. By integrating J+S into SEA, we aim to accelerate the growth of the combined business by enhancing its product and service offerings and broadening its international reach. The transaction will consolidate SEA's position as a leading international provider of naval defence technology.

"Overall, the two acquisitions have together substantially increased the scale, breadth and reach of Cohort's portfolio and are expected to be immediately earnings enhancing. We continue to look for attractive acquisition opportunities while focusing on integrating both businesses and delivering the synergies and growth we have identified."

An analyst conference call will take place at 9.30am this morning. To register please contact MHP (0203 128 8771 or cohort@mhpc.com)

An interview on today's announcement with the CEO of Cohort PLC, Andrew Thomis, will be available at 10:30am via the following link: http://www.brrmedia.co.uk/event/127479

 

Ends

 

For further information please contact:

Cohort plc

0118 909 0390

Andy Thomis, Chief Executive

 

Simon Walther, Finance Director

 

Investec Bank plc

020 7597 5970

Keith Anderson / Daniel Adams

 

MHP Communications Limited

020 3128 8100

Reg Hoare / Vicky Watkins

 

 

NOTES TO EDITORS

Cohort plc

 

Cohort is an independent technology group working primarily for defence (air, land and sea), wider government and industry clients, through four market-facing subsidiary companies:

 

MASS - a specialist systems house with considerable experience in the defence market and a focus on electronic warfare operational support and secure information systems. Based in Cambridgeshire, MASS was acquired by Cohort in August 2006;

 

MCL - an expert in electronic and surveillance technology design and manufacturing, product and in the field support and training for a range of specialist UK end users, including the MOD and other governmental agencies. Based in Surrey, MCL has been part of the Group since July 2014;

 

SCS - a defence technical advisory business, combining technical expertise with practical experience and domain knowledge. Owned by Cohort since flotation in March 2006;

 

SEA - an advanced surveillance systems and software house with hardware development capability operating in the defence, transport and offshore energy market sectors. Acquired by Cohort in October 2007.

 

Cohort was admitted to London's Alternative Investment Market in March 2006. It has its headquarters in Berkshire and employs in total around 500 core staff there and at its other operating company sites in Bristol, Cambridgeshire, Lincolnshire, Somerset and Surrey.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQUROARSVAKOUR
Date   Source Headline
1st Jun 202611:41 amRNSTotal Voting Rights
27th May 20267:00 amRNSFull Year Trading Update
26th May 20267:00 amRNSNotice of Full Year Trading Update
12th May 202610:46 amRNSHolding(s) in Company
1st May 20269:37 amRNSTotal Voting Rights
10th Apr 20263:58 pmRNSDirector/PDMR Shareholding
10th Apr 202612:35 pmRNSHolding(s) in Company
2nd Apr 20267:00 amRNSBlock Listing Six Monthly Return
1st Apr 202610:10 amRNSTotal Voting Rights
26th Mar 20267:00 amRNSContract Announcement
23rd Mar 20267:00 amRNSContract Announcement
2nd Mar 202611:57 amRNSTotal Voting Rights
25th Feb 20269:51 amRNSBlock Listing Six Monthly Return
20th Feb 20267:00 amRNSDirector/PDMR Shareholding
17th Feb 20263:41 pmRNSHolding(s) in Company
16th Feb 20267:00 amRNSDirector/PDMR Shareholding
4th Feb 20269:35 amRNSHolding(s) in Company
2nd Feb 20264:54 pmRNSTotal Voting Rights
30th Jan 20267:00 amRNSContract Wins
20th Jan 202612:40 pmRNSHolding(s) in Company
15th Jan 20267:00 amRNSInterim Report 2025
5th Jan 20269:00 amRNS-RInvestor Presentation via Equity Development
2nd Jan 202612:40 pmRNSTotal Voting Rights
22nd Dec 20259:00 amRNS-RInvestor Presentation via Engage Investor
22nd Dec 20259:00 amRNS-RInvestor Presentation via Engage Investor
15th Dec 202511:56 amRNSDirector/PDMR Shareholding
11th Dec 20257:00 amRNSDirector/PDMR Shareholding
10th Dec 20257:01 amRNSHalf Year Results
1st Dec 202512:20 pmRNSTotal Voting Rights
28th Nov 20257:00 amRNSNotice of Half Year Results
4th Nov 202511:59 amRNSTotal Voting Rights
27th Oct 20254:37 pmRNSDirector/PDMR Shareholding
16th Oct 202510:11 amRNSDirector/PDMR Shareholding
7th Oct 20253:15 pmRNSDirector/PDMR Shareholding
7th Oct 20257:00 amRNSMASS secures £15.7m countermeasures contract
2nd Oct 202511:03 amRNSBlock Listing Six Monthly Return
1st Oct 20259:53 amRNSTotal Voting Rights
25th Sep 20254:59 pmRNSResult of AGM
25th Sep 20257:00 amRNSAGM Statement
19th Sep 20255:12 pmRNSDirector/PDMR Shareholding
12th Sep 20257:00 amRNS-RInvestor Presentation
10th Sep 20253:21 pmRNSDirector/PDMR Shareholding
3rd Sep 202510:57 amRNSDirector/PDMR Shareholding
1st Sep 202511:05 amRNSTotal Voting Rights
26th Aug 20253:22 pmRNSBlock Listing Six Monthly Return
20th Aug 20253:56 pmRNSAnnual Report and Notice of Annual General Meeting
15th Aug 20253:35 pmRNSDirector/PDMR Shareholding
11th Aug 20255:10 pmRNSDirector/PDMR Shareholding
1st Aug 20254:16 pmRNSTotal Voting Rights
17th Jul 20259:49 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.